Retour sur lavenir.net
   WDP 21.740 € (-0,09 %)     VASTNED 29.550 € (+0,17 %)     EVS 29.600 € (-0,67 %)     AB INBEV 70.420 € (-0,25 %)     ACKERMANS V.HAAREN 287.800 € (+0,21 %)     COLRUYT 34.120 € (-2,51 %)     KINEPOLIS GROUP 35.450 € (+0,42 %)     ASCENCIO 51.700 € (0,00 %)     RECTICEL 10.860 € (+2,45 %)     CMB.TECH 12.420 € (-4,02 %)     DEME GROUP 181.800 € (-1,62 %)     SOFINA 221.400 € (-0,81 %)     MELEXIS 83.000 € (+2,79 %)     VAN DE VELDE 30.000 € (-1,32 %)     CIE BOIS SAUVAGE 302.000 € (-1,31 %)     ATENOR 1.770 € (+1,72 %)     BEKAERT 42.100 € (-0,94 %)     PROXIMUS 6.165 € (-1,52 %)     KBC 119.050 € (-0,67 %)     CELYAD ONCOLOGY 0.267 € (-0,74 %)     ARGENX SE 762.800 € (-2,23 %)     AGEAS 67.200 € (-0,81 %)     FAGRON 23.750 € (-0,84 %)     SOLVAC NOM(RETAIL) 77.500 € (+0,65 %)     XIOR 26.000 € (0,00 %)     GIMV 44.650 € (-0,89 %)     TESSENDERLO 20.600 € (0,00 %)     HOME INVEST BE. 19.400 € (-0,41 %)     SHURGARD 24.150 € (+0,84 %)     ELIA GROUP 131.700 € (-1,42 %)     WERELDHAVE BELGIUM 52.200 € (-0,38 %)     ENERGYVISION 14.440 € (-1,90 %)     D'IETEREN GROUP 165.000 € (-1,43 %)     LOTUS BAKERIES 11 260.000 € (-0,35 %)     CAMPINE 222.000 € (-3,06 %)     VIOHALCO 19.740 € (+2,28 %)     FLUXYS BELGIUM D 19.650 € (-1,01 %)     AZELIS GROUP 9.800 € (-2,29 %)     KBC ANCORA 81.800 € (-0,97 %)     TUBIZE-FIN 218.200 € (-1,27 %)     OXURION 0.004 € (-10,00 %)     TITAN S.A. 54.300 € (+1,50 %)     DECEUNINCK 2.275 € (-2,36 %)     IMMOBEL 24.000 € (+4,35 %)     CARE PROPERTY INV. 12.440 € (+0,48 %)     CENERGY 24.980 € (+5,22 %)     UMICORE 23.720 € (-0,92 %)     VGP 82.400 € (+1,60 %)     ONTEX GROUP 2.430 € (+0,41 %)     TINC 11.640 € (-0,51 %)     WHAT'S COOKING GP 145.500 € (+0,34 %)     QUESTFOR GR-PRICAF 2.978 € (+0,12 %)     AGFA-GEVAERT 0.416 € (-0,95 %)     RETAIL ESTATES 68.900 € (-0,86 %)     SOLVAY 27.800 € (+0,58 %)     BARCO 8.690 € (+0,52 %)     BREDERODE 102.400 € (-0,78 %)     SYENSQO 67.600 € (-1,74 %)     JENSEN-GROUP 83.000 € (-0,72 %)     IBA 16.100 € (-3,71 %)  
   ASML HOLDING 1 676.000 € (+1,18 %)     BASTIDE LE CONFORT 23.500 € (-0,21 %)     DERICHEBOURG 9.955 € (-1,73 %)     SOITEC 116.500 € (-6,58 %)     SANOFI 73.340 € (-2,06 %)     LUMIBIRD 24.650 € (+0,20 %)     SCHNEIDER ELECTRIC 291.000 € (+2,92 %)     HAFFNER ENERGY 0.253 € (-6,99 %)     THALES 232.600 € (+0,69 %)     SAFRAN 333.500 € (+2,93 %)     LVMH 505.100 € (-1,15 %)     MAROC TELECOM 9.100 € (+0,44 %)     ARCELORMITTAL SA 55.860 € (-3,39 %)     EUTELSAT COMMUNIC. 2.375 € (-7,01 %)     CIECHARGEURSINVEST 8.260 € (-1,78 %)     CARREFOUR 15.425 € (-6,17 %)     AHOLD DEL 34.520 € (-2,46 %)     VINCI 130.650 € (+0,27 %)     BNP PARIBAS ACT.A 101.100 € (-0,10 %)     ADYEN 903.800 € (+1,74 %)     PROSUS 39.090 € (-0,31 %)     AXA 42.400 € (-0,31 %)     SAINT GOBAIN 79.760 € (+1,12 %)     AIR LIQUIDE 167.120 € (+0,13 %)     LAKEFRONT BIOTHER. 24.580 € (-0,73 %)     EURONEXT 146.300 € (-1,48 %)     EDENRED 24.230 € (+17,17 %)     SPIE 50.450 € (+0,30 %)     WOLTERS KLUWER 58.200 € (-2,68 %)     ONE EXPERIENCE 0.362 € (-15,54 %)     NANOBIOTIX 30.400 € (-0,91 %)     MOTA ENGIL 4.598 € (-2,38 %)     SAFE 0.570 € (+1,79 %)     STELLANTIS NV 5.570 € (-3,65 %)     SCOR SE 31.140 € (-0,70 %)     REMY COINTREAU 45.420 € (+2,76 %)     WINAMP GROUP 0.386 € (-1,28 %)     LLAMA GROUP 0.386 € (-1,28 %)     VALEO 13.410 € (-5,06 %)     EXAIL TECHNOLOGIES 106.400 € (+0,66 %)     RAMSAY GEN SANTE 11.000 € (-1,35 %)     AIRBUS 191.940 € (+2,63 %)     JCDECAUX 19.380 € (-1,42 %)     INNATE PHARMA 1.598 € (+1,14 %)     BE SEMICONDUCTOR 317.800 € (+2,48 %)     PLANISWARE 18.000 € (-3,23 %)     VERALLIA 19.480 € (-2,01 %)     AKZO NOBEL 59.620 € (+1,05 %)     SHELL PLC 34.210 € (-2,56 %)     RELX 27.220 € (-4,02 %)     VOPAK 45.100 € (-0,88 %)     ASM INTERNATIONAL 1 070.500 € (+2,34 %)     THERMADOR GROUPE 69.300 € (-0,72 %)     OSE IMMUNO 3.584 € (-4,32 %)     BOLLORE 5.400 € (-0,74 %)     LECTRA 16.660 € (+0,73 %)     KERING 276.550 € (+4,40 %)     BUREAU VERITAS 26.210 € (+0,54 %)     ALTAREA 96.300 € (-0,52 %)     IMERYS 22.520 € (-0,09 %)  
News Réglementées
16/02/2023 08:00

Dalata Hotel Group PLC: Purchase of new London Hotel

Dalata Hotel Group PLC (DAL,DHG)
Dalata Hotel Group PLC: Purchase of new London Hotel

16-Feb-2023 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


 

Dalata Hotel Group announces purchase of new London hotel for £44.3 million

The Group’s first Maldron Hotel in London

 

ISE: DHG              LSE: DAL

Dublin and London | 16 February 2023: Dalata Hotel Group plc ("Dalata" or "the Group"), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, is pleased to announce the addition of a new 192-bedroom hotel at 240 Seven Sisters Road, Finsbury Park, North London to its hotel portfolio. Under the transaction, Dalata has acquired the entire issued share capital of Tide Developments (4) Limited (“TD4”) for a total consideration of £44.3 million (€49.7 million) from Furadino Holdings Limited. TD4 has a gross asset value of £45.1 million and owns the freehold interest of the hotel property. The total consideration will be financed from Dalata’s existing cash and banking facilities.

The newly finished hotel, which has never traded, consists of 192 bedrooms, ground floor lobby and a restaurant and bar. Prior to opening in summer 2023, Dalata will invest in excess of
£2 million to enhance the property and launch under the Maldron brand. The hotel, with an expectation of stabilised annual earnings of £4 million, will be Dalata’s first Maldron hotel in London, its 18th hotel in the UK and will create over 50 jobs locally. Conveniently located within walking distance of the Emirates Stadium, the hotel is adjacent to Finsbury Park Station, with extensive National Rail, London Underground and bus services offering direct links to King’s Cross St Pancras and the centre of London.

The property was constructed using the Vision Modular System, which can result in as much as a 40 per cent saving in the embodied carbon emissions when compared with traditional methods of construction. The sustainably designed hotel is BER A rated, includes photovoltaic panels, and is expected to achieve BREEAM ‘Excellent’ accreditation.

Dermot Crowley, CEO, Dalata commented on the announcement:

“London is a key strategic growth market for Dalata. We are very excited to be opening our first Maldron hotel in the city in advance of our Maldron in Shoreditch which is currently under construction. This acquisition represents an outstanding opportunity to operate a new, sustainably built, hotel in a vibrant and developing area as we continue our ambitious UK expansion plan. The strength of our balance sheet has been a crucial element in enabling us to make this investment as we continue to create value for all of our stakeholders.”

Shane Casserly, Corporate Development Director, Dalata added:

“Acquiring a new hotel asset in London, in challenging funding markets, that will be operational in the summer of 2023, is a fantastic achievement by the Group. This transaction highlights our appetite for growth as well as the flexibility of our business model, which enables us to grow through acquisition, development and leasing. We are excited by the excellent sustainability credentials of the property as we continue to make progress on our ambitious targets.”  

ENDS

 

About Dalata

Dalata Hotel Group plc was founded in August 2007, listed as a plc in March 2014 and is now Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group operates two primary hotel brands, Clayton Hotels and Maldron Hotels. The Group’s portfolio comprises 50 primarily 4-star hotels situated in city-centre locations with over 10,950 rooms across 29 owned hotels, 18 leased hotels and three management contracts. The Group has ambitious expansion plans for the UK and continental Europe with a committed pipeline of over 1,300 rooms. For the first six months of 2022, Dalata reported revenue of €220.2 million and a profit after tax of €46.7 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com

 

Contacts

Dalata Hotel Group plc

Tel +353 1 206 9400

Dermot Crowley, CEO

investorrelations@dalatahotelgroup.com

Shane Casserly, Corporate Development Director

Carol Phelan, CFO

 Graham White, Head of Investor Relations

 

Joint Company Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

Melanie Farrell

dalata@fticonsulting.com

 

__________________________

 

 



ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:ACQ
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
OAM Categories:3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:223503
EQS News ID:1561077

 
End of AnnouncementEQS News Service

fncls.ssp?fn=show_t_gif&application_id=1561077&application_name=news&site_id=symex

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière